Zobrazeno 1 - 10
of 22
pro vyhledávání: '"A.Y. Kulikov"'
Publikováno v:
Pharmacoeconomics: theory and practice. 9:17-36
We conducted an budget impact analysis was made of the treatment of spinal muscular atrophy (SMA) with drugs Nusinersen and Risdiplam. Its results showed that from the point of view of the organization of drug provision for patients with SMA at curre
Publikováno v:
Pharmacoeconomics: theory and practice. 9:11-16
The global pharmacoeconomic model of cost-effectiveness analysis of insulin degludec (Tresiba®) use in comparison with insulin glargine U300 in the treatment of type 2 diabetes mellitus, was validated. As the result, it was found that the model is r
Autor:
D.A. Sytnik, S.V. Popov, A.Y. Kulikov, E.A. Grin, M M Suleymanov, I.S. Pazin, Russia Saint-Petersburg, I.N. Orlov
Publikováno v:
Experimental and Сlinical Urology. 14:52-57
Introduction. The problem of urolithiasis remains relevant throughout the world. The widespread prevalence of the disease is the reason for the search for new and effective methods of dealing with various complications of surgical treatment in order
Autor:
A.Y. Kulikov, I N Orlov, N Y Spiridonov, S V Popov, V M Obidnyak, N K Gadjiev, G.N. Akopyan, D.A. Sytnik, Z K Gadzhieva
Publikováno v:
Urologiia. :44-47
Introduction & Objectives. Rectal injury and recto-urethral fistula (RUF) formation are severe complications after surgical treatment of prostate cancer . There are various surgical techniques as well as conservative methods for the treatment of RUF.
Autor:
E.I. Makarova, A.Y. Kulikov
Publikováno v:
Pharmacoeconomics: theory and practice. 5:59-63
Autor:
A.Y. Kulikov, E.I. Makarova
Publikováno v:
Pharmacoeconomics: theory and practice. 5:45-53
Publikováno v:
Pharmacoeconomics: theory and practice. 5:29-33
Autor:
A.Y. Kulikov, E.V. Strygina
Publikováno v:
Tambov University Reports. Series: Natural and Technical Sciences. 21:2326-2329
Autor:
E.V. Strygina, A.Y. Kulikov
Publikováno v:
Tambov University Reports. Series: Natural and Technical Sciences. 22:1389-1391
Publikováno v:
Pharmacoeconomics: theory and practice. 1:3-34